🇵🇹

First Pharma Fund

Companies holding Pharmacy Licenses

Min. Investment
€100,000
Expected Returns
9.5% p.a.
Term
10 Years
Sector
Healthcare

Key Terms Summary

Target Fund Size€16.0M
Target IRR9.5%
Subscription Fee1.50%
Management Fee0.60% p.a.
Performance Fee20% of fund returns above a hurdle rate of 3,5% p.a.
Distribution PolicyFund maturity
Fund Start6/1/2024
Fund Closing6/1/2034
Subscription Deadline12/1/2026
Participation Unit€1,000
US Citizens AcceptedNo
Risk ProfileAggressive

Eligibility & Program Fit

Suitable for non-EU/EEA/Swiss nationals seeking Portugal residency.

Ideal for aggressive risk tolerance investors looking for healthcare exposure.

Meets the minimum investment requirement for the Portugal Golden Visa program.

Designed for those comfortable with a 10 years lock-in period for their capital.

Note: This fund does not accept US citizens. Please verify eligibility requirements with the fund.

Risks & Considerations

Important Information

Investment in healthcare funds involves risk, including the potential loss of the entire investment. Past performance is not indicative of future results. Market fluctuations, regulatory changes in immigration law, and fund management performance can all impact returns. Investors should conduct their own due diligence and consult with financial and legal advisors before making any investment decisions.

Request More Information

Get the official fund documentation, a personalized eligibility check, and speak with an advisor.

First Pharma Fund - Portugal Golden Visa Fund | Renova Wealth